March 2015 3CTN Network Pulse

March2014
2015
March
The Network Pulse
What’s New?
Ready… Set… RECRUIT!
The many milestone ‘firsts’ achieved this month prove that implementation of the
3CTN Network is off to a roaring start - read on to see our recent and exciting
achievements
FIRST Funding Installment to Network Sites
The Coordinating Centre is pleased to announce a major milestone - a total of 20
Network sites have now received their first funding installment. These funding
installments were awarded to two NRCCs, six NCCs, 12 NACCs and will have a big
impact on site activities as well as translate into increased recruitment to academic
clinical trials. Your site hasn’t received 3CTN funding yet? Never fear! Contract
negotiations are currently underway with the rest of the Network’s NRCCs/NCCs
and the remaining NACCs contracts will be finalized in the upcoming NACC RFA
(see “Key Dates” for details).
FIRST Recruitment Reports Received
Site recruitment reports are an important tool to monitor 3CTN’s objective of
increasing patient recruitment by 50 per cent across the Network by 2018. This
month, the Network’s first “Quarterly Recruitment Reports” were submitted by 47
sites across Canada. These reports represent third quarter (Oct - Dec) recruitment
activities and the numbers show great promise with 14 sites on target to exceed
their baseline recruitment in the first year. The fourth quarter recruitment reports are
due in May, so stay tuned for a summary in a future newsletter.
“We are pleased to be playing a part
in this critically important effort.”
Dr. Joe Pater
FIRST discussion of ‘Live’ Portfolio
The 3CTN Portfolio is now ‘live’ on the website and the recent Portfolio Committee
(PC) meeting was an opportunity for the PC to change gears. “It’s very satisfying
for me and the entire Portfolio Committee to have moved from the development to
the implementation phase of the 3CTN initiative. Our focus has shifted to applying
the portfolio criteria consistently and transparently to the wide range of studies that
are now “live” on the 3CTN website. We are pleased to be playing a part in this
critically important effort.” Joe Pater, Chair of the PC.
The 3CTN Coordinating Centre team wants to extend our gratitude to everyone
across the Network who has played a role in achieving these milestones. Surely,
with such positive signs of progress, our collective efforts will ensure nation-wide
enhancement of the academic clinical trial landscape in the months and years to
come.
Contact Us - For inquiries please contact: [email protected] or call 1-866-678-6427








NACC RFA Round 1 approved
and contracts finalized;
First payments issued to 20
Network sites;
Four additional funder contracts
finalized;
Steering Committee (SC), PC
and inaugural Scientific Advisory
Board meetings held;
Strategic Council established,
first meeting scheduled;
Updated portfolio application
form and new 3CTN peer review
guidelines available on
www.3ctn.ca;
EDGE training sessions held at
pilot sites;
Bernie Eigl was elected ViceChair of the SC and Gerald
Batist was elected as the NRCC
Associate Director
representative to serve on the
3CTN Executive Committee.
3CTN in the News
3CTN’s collaboration with Janssen
Inc. ‘will develop more clinical trials
and other translational research
projects that address important
clinical questions in prostate cancer.’
Read the news release here: OICR
extends collaboration with Janssen
Inc. to develop clinical trials for
prostate cancer
The Network Pulse
March 2014
Network Site Progress
What’s New with EDGE?
Key Dates
The 3CTN Coordinating Centre has been working on implementing EDGE, a
clinical trials management system. I am interested in using EDGE. What’s
next?
March 20 or 26, 2015: EDGE
Demo Session
1. Awareness
• Expression of
interest
• Attend demo
session
• Review 'Readiness
Checklist'
• Prepare for site
training and data
migration
2. Training and
Configuration
• Train the trainers
• Provide training to
local staff
• Practice in BETA
version
• System
configuration
3. Go Live
• Execute
Agreement
• End user
training
• Provide access
to users
Demos will be offered monthly.
Register: [email protected]
April 1, 2015: NACC RFA Round
2 Released
April 6 or 8, 2015: Financial
Reporting Information Session
Register: [email protected]
April 7 or 9, 2015: Progress
Reporting Information Session
Register: [email protected]
Contact Rebecca Xu for an invite to the next Canadian EDGE demo session
on March 20,10-11:30 a.m. (EDT) and March 26, 2015, 11:30 a.m.-1 p.m.
(EST)
November 6, 2015: 3CTN
Annual Stakeholder Meeting
3CTN Welcomes Four New Funders!
3CTN is pleased to announce the receipt of funding from four additional partners. 3CTN welcomes Alberta
Cancer Foundation, British Columbia Cancer Agency, New Brunswick Health Research Foundation and Nova
Scotia Health Research Foundation as they join our list of partners. 3CTN will continue to work with Quebec
funders to execute agreements in the near future.
Contact Us
For inquiries please contact: [email protected] or call 1-866-678-6427
Canadian Cancer Clinical Trials Network, MaRS Centre, 661 University Ave,
Suite 510 Toronto, Ontario Canada M5G 0A3
www.3ctn.ca